Perhavec A - Search Results

Year	Number of Results
2007	2
2008	2
2009	1
2010	1
2011	2
2012	4
2013	2
2014	2
2016	1
2017	3
2019	1
2020	7
2021	5
2022	3
2023	5
2024	2

1

Targeted axillary dissection: worldwide variations in clinical practice.

Kontos M, Kanavidis P, Kühn T, Masannat Y, Gulluoglu B; TAD Study Group. Kontos M, et al. Breast Cancer Res Treat. 2024 Apr;204(2):389-396. doi: 10.1007/s10549-023-07204-7. Epub 2024 Jan 4. Breast Cancer Res Treat. 2024. PMID: 38175449

2

Inoperable Primary Retroperitoneal Sarcomas: Clinical Characteristics and Reasons Against Resection at a Single Referral Institution.

Perhavec A, Provenzano S, Baia M, Sangalli C, Morosi C, Barisella M, Colombo C, Radaelli S, Pasquali S, Callegaro D, Gronchi A, Fiore M. Perhavec A, et al. Ann Surg Oncol. 2021 Feb;28(2):1151-1157. doi: 10.1245/s10434-020-08789-9. Epub 2020 Jul 6. Ann Surg Oncol. 2021. PMID: 32632883

3

General Overview and Treatment Recommendations for Young Women with Breast Cancer.

Ribnikar D, Ratoša I, Perhavec A, Amir E. Ribnikar D, et al. Among authors: perhavec a. Rev Invest Clin. 2017 Mar-Apr;69(2):77-93. doi: 10.24875/ric.17002175. Rev Invest Clin. 2017. PMID: 28453506 Free article. Review.

4

A predictive tool to estimate the risk of axillary metastases in breast cancer patients with negative axillary ultrasound.

Meretoja TJ, Heikkilä PS, Mansfield AS, Cserni G, Ambrozay E, Boross G, Zgajnar J, Perhavec A, Gazic B, Arisio R, Tvedskov TF, Jensen MB, Leidenius MH. Meretoja TJ, et al. Among authors: perhavec a. Ann Surg Oncol. 2014 Jul;21(7):2229-36. doi: 10.1245/s10434-014-3617-6. Epub 2014 Mar 25. Ann Surg Oncol. 2014. PMID: 24664623

5

Axillary ultrasound for predicting response to neoadjuvant treatment in breast cancer patients-a single institution experience.

Pislar N, Gasljevic G, Music MM, Borstnar S, Zgajnar J, Perhavec A. Pislar N, et al. Among authors: perhavec a. World J Surg Oncol. 2023 Sep 16;21(1):292. doi: 10.1186/s12957-023-03174-8. World J Surg Oncol. 2023. PMID: 37715188 Free PMC article.

6

Variation in response rates to isolated limb perfusion in different soft-tissue tumour subtypes: an international multi-centre study.

Reijers SJM, Davies E, Grünhagen DJ, Fiore M, Honore C, Rastrelli M, Vassos N, Podleska LE, Niethard M, Jakob J, Perhavec A, Duarte C, González F, Deroose JP, Stas M, Boecxstaens V, Schrage Y, Snow H, Algarra SM, Said HM, Garcia-Ortega DY, Martin K, Mattsson J, Djafarrian R, Di Lorenzo G, Colombo C, Gronchi A, Matter M, Verhoef C, Olofsson Bagge R, Hohenberger P, Hayes AJ, van Houdt WJ. Reijers SJM, et al. Among authors: perhavec a. Eur J Cancer. 2023 Sep;190:112949. doi: 10.1016/j.ejca.2023.112949. Epub 2023 Jun 20. Eur J Cancer. 2023. PMID: 37453241

7

Intraoperative Touch Imprint Cytology in Breast Cancer Patients After Neoadjuvant Chemotherapy.

Hadalin V, Pislar N, Borstnar S, Matos E, Kovac A, Dobovisek L, Cankar K, Perhavec A. Hadalin V, et al. Among authors: perhavec a. Clin Breast Cancer. 2022 Jun;22(4):e597-e603. doi: 10.1016/j.clbc.2021.12.013. Epub 2022 Jan 5. Clin Breast Cancer. 2022. PMID: 35086763

8

Primary localized retroperitoneal sarcomas: report from Slovenian sarcoma referral center.

Novak M, Perhavec A, Kerin Povšič M, Arnuš M, Eržen D. Novak M, et al. Among authors: perhavec a. World J Surg Oncol. 2020 Oct 27;18(1):277. doi: 10.1186/s12957-020-02038-9. World J Surg Oncol. 2020. PMID: 33109203 Free PMC article.

9

International multicenter tool to predict the risk of nonsentinel node metastases in breast cancer.

Meretoja TJ, Leidenius MH, Heikkilä PS, Boross G, Sejben I, Regitnig P, Luschin-Ebengreuth G, Žgajnar J, Perhavec A, Gazic B, Lázár G, Takács T, Vörös A, Saidan ZA, Nadeem RM, Castellano I, Sapino A, Bianchi S, Vezzosi V, Barranger E, Lousquy R, Arisio R, Foschini MP, Imoto S, Kamma H, Tvedskov TF, Kroman N, Jensen MB, Audisio RA, Cserni G. Meretoja TJ, et al. Among authors: perhavec a. J Natl Cancer Inst. 2012 Dec 19;104(24):1888-96. doi: 10.1093/jnci/djs455. Epub 2012 Nov 1. J Natl Cancer Inst. 2012. PMID: 23117131

10

Does concurrent gynaecological surgery affect infectious complications rate after mastectomy with implant-based reconstruction?

Pislar N, Peric B, Ahcan U, Cencelj-Arnez R, Zgajnar J, Perhavec A. Pislar N, et al. Among authors: perhavec a. Radiol Oncol. 2022 Jul 20;57(1):80-85. doi: 10.2478/raon-2022-0026. eCollection 2023 Mar 1. Radiol Oncol. 2022. PMID: 35853741 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

35 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

35 results

Results by year